Tenet Healthcare Down 60.6% YTD: Should You Buy The Dip?
Zacks Investment Research | Mar 16, 2020 09:43PM ET
Tenet Healthcare Inc. (NYSE:THC) stock is under pressure due to the coronavirus outbreak which requires hospitals to keep their elective procedures on hold to accommodate any potential surge in admissions.
The U.S. Centers for Disease Control (CDC) and Prevention has recommended that hospital elective procedures, surgeries and non-urgent outpatient visits be postponed once the virus has started to spread through a community.
If coronavirus cases continue to rise, hospitals might experience a surge in admissions, diagnostic requests, drug prescriptions and increased need for ICU capacity and staffing.
However, cancellation in elective surgeries to accommodate coronavirus-infected patients will hurt the company’s revenues, which is already highly leveraged. Notably, Community Health Systems is the most levered of the public hospitals with a 2019 net Debt/EBITDA of 8.1x compared with 5.7x for Tenet Healthcare and 3.4x for HCA Healthcare, Inc. (NYSE:HCA) .
Moreover, it is feared that coronavirus outbreak may cause recession. Such an economic situation may lead to loss of jobs, which would mean less number of people covered by private insurance and more number of people with insurance from Government health schemes – Medicare and Medicaid. Since profitability of the Government sponsored health insurance plans is lower than that covered under employer sponsored plans, margins of the hospitals are likely to take a hit. Higher number of individuals without sufficient health insurance cover might also lead to hospitals facing the issue of bad debts from unpaid medical bills.
Year to date, shares of Tenet Healthcare have lost 60.6% compared with the industry ’s decline of 31%.
This decline in share price presents a good buying opportunity for investors. The stock carries a Zacks Rank #2 (Buy) and has an impressive Value Score of A. Our research shows that stocks with a Value Style Score of A or B when combined with a Zacks Rank #1 (Strong Buy) or 2 offer the best opportunities in the value investing space.You can see .
Tenet Healthcare’s strategic divestitures have helped to streamline its business by focusing on core operations and debt repayment. Its spin-off of Conifer business, expected to close by the end of 2021, is likely to further reduce its debt burden. Accretive acquisitions are significantly strengthening its top line. Its cost-reduction program is likely to favor earnings.
Year to date, other companies in the same space such as Community Health Systems, Inc. (NYSE:CYH) , United Health Services, Inc. (NYSE:UHS) and HCA Healthcare have lost 12.4%, 43.1% and 42.9%, respectively.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Get The News You Want
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.